Last checked at | Thursday 25 April | |
| Acacia Mining | Q1 Results |
| RELX | Trading Statement |
| Anglo American | Q1 Production |
| Devro | Trading Statement |
| RDI REIT | Half Year Results |
| Tullow Oil | Trading Statement |
| Barclays | Q1 Results |
| KAZ Minerals | Q1 Results |
| Senior | Trading Statement |
| Meggitt | Trading Statement |
| Taylor Wimpey | Trading Statement |
| Synthomer | Trading Statement |
| Carpetright | Trading Statement |
| Friday 26 April | |
| WPP | Q1 Results |
| Hastings Group | Q1 Results |
| Allied Minds | Full Year Results |
| Computacenter | Q1 Results |
| Rotork | Trading Statement |
| Royal Bank of Scotand Group | Q1 Results |
| Just Eat | Q1 Results |
| AstraZeneca | Q1 Results |
| AJ Bell | Trading Statement |
| Georgia Capital | Q1 Results |
| Monday 29 April | |
| Evraz | Q1 Results |
| UP Global Sourcing | Half Year Results |
| Horizon Discovery Group | Full Year Results |
| River & Merantile | Q3 Results |
| Tuesday 30 April | |
| BP | Q1 Results |
| Standard Chartered | Q1 Results (at 0515 BST) |
| Elementis | Trading Statement |
| Glencore | Q1 Production |
| St James's Place | Q1 Results |
| Whitbread | Full Year Results |
| Weir Group | Q1 Results |
| Breedon Group | Trading Statement |
| Jupiter Fund Management | Q1 Results |
| Hochschild Mining | Q1 Production |
| Greene King | Trading Statement |
| C4X Discovery | Half Year Results |
| Animalcare | Full Year Results |
| Xeros Technology Group | Full Year Results |
| Focusrite | Half Year Results |
| Wednesday 1 May | |
| J Sainsbury | Full Year Results |
| Connect Group | Half Year Results |
| Indivior | Q1 Results |
| AIB Group | Q1 Results |
| London Stock Exchange Group | Q1 Results |
| Metro Bank | Q1 Results |
| IWG | Q1 Results |
| Inmarsat | Q1 Results |
| Next | Q1 Results |
| Persimmon | Trading Statement |
| GlaxoSmithKline | Q1 Results (at 1200 BST) |
| Rank Group | Trading Statement |
| RPS Group | Trading Statement |
| Avon Rubber | Half Year Results |
Today 08:49
GSK's depemokimab asthma treatment meets endpoints in latest trials
(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.
Read more